Elucidating the Causal Relationships between Circulating Inflammatory Proteins and Sepsis Outcomes: A Mendelian Randomization Approach.

IF 3.5 4区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Peng Wang, Hou'an Xiao, Xiaoqian Zhou, Qian Kou
{"title":"Elucidating the Causal Relationships between Circulating Inflammatory Proteins and Sepsis Outcomes: A Mendelian Randomization Approach.","authors":"Peng Wang, Hou'an Xiao, Xiaoqian Zhou, Qian Kou","doi":"10.2174/0109298673344958250319074101","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Sepsis has been associated with numerous circulating proteins, yet traditional studies have struggled to clarify whether these protein biomarkers directly contribute to disease progression.</p><p><strong>Methods: </strong>Our study aimed to explore the causal effects of 91 circulating inflammation- related proteins (CIPs) on sepsis using a two-sample Mendelian randomization (MR) approach. We employed the inverse variance weighted (IVW) method as our primary analytical tool, supplemented by additional methods, such as weighted median, weighted mode, simple median, MR-Egger, and MR-PRESSO analyses. Comprehensive sensitivity analyses were carried out to rigorously assess the robustness of our findings, which substantiated the lack of significant heterogeneity and ruled out the presence of horizontal pleiotropy.</p><p><strong>Results: </strong>Our study identified 2 CIPs with statistically significant causal effects on sepsis: fractalkine (OR=2.383, 95% CI=1.380-4.113, p=0.002) and IL-12 (OR=0.780, 95% CI=0.610-0.997, p=0.047). These results suggested that fractalkine and IL-12 might play a contributory role in the risk of sepsis. The implications of our findings are substantial, highlighting fractalkine and IL-12 as potential therapeutic targets for sepsis prevention and treatment. The reliability of our results was further reinforced by sensitivity analyses, which demonstrated no evidence of heterogeneity or pleiotropy.</p><p><strong>Conclusion: </strong>This study offered new insights into sepsis pathophysiology and identified potential therapeutic targets. Further studies are required to validate these findings and elucidate the precise roles of these proteins.</p>","PeriodicalId":10984,"journal":{"name":"Current medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0109298673344958250319074101","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Sepsis has been associated with numerous circulating proteins, yet traditional studies have struggled to clarify whether these protein biomarkers directly contribute to disease progression.

Methods: Our study aimed to explore the causal effects of 91 circulating inflammation- related proteins (CIPs) on sepsis using a two-sample Mendelian randomization (MR) approach. We employed the inverse variance weighted (IVW) method as our primary analytical tool, supplemented by additional methods, such as weighted median, weighted mode, simple median, MR-Egger, and MR-PRESSO analyses. Comprehensive sensitivity analyses were carried out to rigorously assess the robustness of our findings, which substantiated the lack of significant heterogeneity and ruled out the presence of horizontal pleiotropy.

Results: Our study identified 2 CIPs with statistically significant causal effects on sepsis: fractalkine (OR=2.383, 95% CI=1.380-4.113, p=0.002) and IL-12 (OR=0.780, 95% CI=0.610-0.997, p=0.047). These results suggested that fractalkine and IL-12 might play a contributory role in the risk of sepsis. The implications of our findings are substantial, highlighting fractalkine and IL-12 as potential therapeutic targets for sepsis prevention and treatment. The reliability of our results was further reinforced by sensitivity analyses, which demonstrated no evidence of heterogeneity or pleiotropy.

Conclusion: This study offered new insights into sepsis pathophysiology and identified potential therapeutic targets. Further studies are required to validate these findings and elucidate the precise roles of these proteins.

阐明循环炎症蛋白与败血症结局之间的因果关系:孟德尔随机化方法。
导论:脓毒症与许多循环蛋白有关,然而传统研究一直在努力阐明这些蛋白质生物标志物是否直接促进疾病进展。方法:我们的研究旨在探讨91循环炎症相关蛋白(cip)对脓毒症的因果关系,采用双样本孟德尔随机化(MR)方法。我们采用逆方差加权(IVW)方法作为主要分析工具,并辅以加权中位数、加权模式、简单中位数、MR-Egger和MR-PRESSO分析等其他方法。我们进行了全面的敏感性分析,以严格评估我们研究结果的稳健性,证实缺乏显著的异质性,并排除了水平多效性的存在。结果:我们的研究确定了2种与脓毒症有显著因果关系的CIPs: fractalkine (OR=2.383, 95% CI=1.380-4.113, p=0.002)和IL-12 (OR=0.780, 95% CI=0.610-0.997, p=0.047)。这些结果表明fractalkine和IL-12可能在脓毒症的风险中起一定的作用。我们的发现意义重大,突出了fractalkine和IL-12作为脓毒症预防和治疗的潜在治疗靶点。敏感性分析进一步加强了结果的可靠性,没有证据表明存在异质性或多效性。结论:本研究为脓毒症的病理生理学提供了新的见解,并确定了潜在的治疗靶点。需要进一步的研究来验证这些发现并阐明这些蛋白质的确切作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current medicinal chemistry
Current medicinal chemistry 医学-生化与分子生物学
CiteScore
8.60
自引率
2.40%
发文量
468
审稿时长
3 months
期刊介绍: Aims & Scope Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信